Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just like Kong’s shouldn’t get depressed on down days, nobody should be celebrating just yet!
Know what you own and understand that this is a gem if you have patience’s .
No cover . Buying
Really straight forward. Preds year runs June to June so not only is it end of quarter it’s also the end of year for them and as such that takes a bit longer as the Q has to be completed and audited and then the full 12 months have to be rechecked. Auditors and attorneys take their time and there’s a lot of moving parts here so it’s best to be careful. Hope that answers your question
For anyone new here
All you need to know about pred. Forget the noise, stay focused on the fundamentals and where this company is going.
Pred attorneys who facilitated all the m&a in the company .https://bestlawfirms.usnews.com/profile/wilson-sonsini-goodrich-rosati-pc-llo/rankings/13129
Small Outfit !!
The Auditors who have had their name dragged through the mud BF Borgers rank number 7 in the entire country dealing with otc ! Deloitte are number 6 and KPMG are number 8!
https://blog.auditanalytics.com/who-audits-public-companies-2019-edition/
Relative comparison pred v adpt
Similar but not exact business but very comparable
Pred revenue projected $55m
Adpt rev $55m https://craft.co/adaptive-biotechnologies/metrics
Adpt market cap $5b
Pred market cap $700m
Adpt revenue multiple 100x
Pred revenue multiple 12x
Adpt on nasdaq
Pred on way to nasdaq
Pps adpt $39
Pps pred $1-60
Number of products adpt 1
Number of products pred multiple
Adpt partners Microsoft
Pred IQVIA and ThermoFisher
Employees adpt 300
Employees pred 200 and growing
Only difference is time. It’s going to happen
Here’s everything else on pred
I know there’s a lot of excitement with this “big hitter” going after Hindenburg and the “shorts” and that’s great but it doesn’t help you today other than making you feel a bit better and having a white knight ride to your aid. It’s not important. The important things are listed below and the company fundamentals are continuing to improve.
One of our would be experts has pulled distorted financials out to validate his doomsday scenario. The company is surrounded by deep pockets, has never gone into the market for money and is cash flowing with increasing revenues, building out new facilities and hiring world class team.
A example of real world values in this field is adpt which just did an iPo and has a $6B market cap and a $40 share price. It has less revenue, relies on one product and the team is a shadow of the team in pred.It has about 10% of what pred has! This will be proven out.
Everyone would have loved to sell at $6-90 and buy back yesterday but 1% do that. You are not stupid. It’s the way it is. The company is legit, the people are legit and the relationships are legit. Don’t get caught in the short sighted daily game. Do you’re own homework, I’ve taken a lot of the work out of it for you below. It’s easy to fool one big guy into joining you but you can’t fool the best of the best in the medical world, pfe, tmo, as well as the best Kesha’s minds Wilson sonsini (their partner joined the board) , the top Nasdaq guys, form 10 through the second and also zacks did a full review https://s1.q4cdn.com/460208960/files/News/2019/Zacks_SCR_Research_06112019_PRED_Vandermosten.pdf
This will end and recover and we still have one of the best companies on the street and this will be proven out
Here’s the only thing that matters
Have to add cellsure to this now https://parentsguidecordblood.org/en/news/cellsure-brings-disruptive-innovation-banking-stem-cells
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood (CB), tissue, and placenta storage coupled with increasing number of service providers offering services at competitive prices are the factors driving the market growth.
Here’s my 2 cents for what’s it’s worth
Classic bear raid and attack piece by this Hindenburg group that clearly states he’s short!
“Hindenburg Research (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a short position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein declines. ”
Look at the logic here, the article was totally biased and used info that was completely incorrect to spook people and it worked.
Ex chairman (ex being the key) had sec issues. False and as shown elsewhere they were dropped so therefore no issues.
Company procedures and process are a fraud and don’t work, yet they are at world conferences releasing new data to the best in the world. http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/ Then TMO, one of the largest biotechs in the world does a partnership with them. Who do you think knows more! http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
Let’s look at the team, ex execs from Pfizer, ING, Wyatt, ex president of the American Medical Association, one of the leading senators over the last 100 years and the list goes on. http://predtechgroup.com/about/
The leading attorneys when it comes to biotech Wilson sonsini (they probably have a good idea what’s going on internally) https://www.wsgr.com/WSGR/Display.aspx?SectionName=about the ex senior counsel and ex president of nasdaq is leading their Nasdaq uplist process.https://www.donohoeadvisory.com/about-us/david-a-donohoe-jr/
Let’s also look at the fundamentals
Form 10 passed 30 days ago! If any of this article was remotely true then the would never have passed sec scrutiny and got their form 10! https://www.sec.gov/Archives/edgar/data/1382943/000000000019009260/filename2.txt
Revenues growing q over q! I’m assuming this Q will be the same.
IQVIA (multi billion dollar company) leading one of their fda trials http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
Major partnership with ThermoFisher
It’s hard to look at but this will all wash out and company will uplist and get it’s true value point when the big boys come in. Right now it’s easy to scare retail investors and this was their last chance and they took it. It’s shitty and unfair but it’s the way the market works.
As I always say, do your homework and know what you own
All the recent press and it’s extensive
http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/
http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
http://predtechgroup.com/2019/05/predictive-technology-group-announces-enrollment-milestone-of-200-participants-in-predictive-laboratories-study-for-chronic-joint-and-spine-pain/
http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
http://predtechgroup.com/press/
Well lookey lookey
Time to start the engines!!!
You can’t pull out an exception to the rule and use that as the norm! Wise up
Why not use gates, Buffett, zukerburg or anyone of 1000 successful companies and stories
All this “short” talk is background noise , it’s all going to come down to fundamentals and time. The fundamentals are there, it’s just up to everyone to figure out what their patience’s level is. This attack hurt short term and there’s a lot of “what if’s” however you can’t undo anything.
Keep digging on the fundamentals and $2 will be a distant memory in the nit too distant future
They do that when they officially announce the results. When they are fully audited
Growth means growth a we know worst case it’s north of 12m which is great.
Re releasing financials, it’s eoy as well as Q so all those numbers have to audited. Standard procedure. Nothing untoward so move on
That’s your opinion and you’re entitled to it. I happen to disagree and why dignify it with a detailed response. You’re thinking like a short termer. The company executing will speak for louder than
“It’s not true” PR
It’s very simple
There won’t be a press release from the company. Nasdaq press release the uplist snd 72 hours later the company trades on the higher exchange.
If a company is declined for a particular reason, the company within 72 hours has to disclose that.
As it stands, the application process started on June 3rd and normally takes 6-12 weeks so we are in the window. All of this is at nasdaq discretion
Why would you be getting paperwork? When the investor releases the info you provide the info to them. It’s unimportant
All you need to know about pred. Forget the noise, stay focused on the fundamentals and where this company is going.
Pred attorneys who facilitated all the m&a in the company .https://bestlawfirms.usnews.com/profile/wilson-sonsini-goodrich-rosati-pc-llo/rankings/13129
Small Outfit !!
The Auditors who have had their name dragged through the mud BF Borgers rank number 7 in the entire country dealing with otc ! Deloitte are number 6 and KPMG are number 8!
https://blog.auditanalytics.com/who-audits-public-companies-2019-edition/
Relative comparison pred v adpt
Similar but not exact business but very comparable
Pred revenue projected $55m
Adpt rev $55m https://craft.co/adaptive-biotechnologies/metrics
Adpt market cap $5b
Pred market cap $700m
Adpt revenue multiple 100x
Pred revenue multiple 12x
Adpt on nasdaq
Pred on way to nasdaq
Pps adpt $39
Pps pred $1-60
Number of products adpt 1
Number of products pred multiple
Adpt partners Microsoft
Pred IQVIA and ThermoFisher
Employees adpt 300
Employees pred 200 and growing
Only difference is time. It’s going to happen
Here’s everything else on pred
I know there’s a lot of excitement with this “big hitter” going after Hindenburg and the “shorts” and that’s great but it doesn’t help you today other than making you feel a bit better and having a white knight ride to your aid. It’s not important. The important things are listed below and the company fundamentals are continuing to improve.
One of our would be experts has pulled distorted financials out to validate his doomsday scenario. The company is surrounded by deep pockets, has never gone into the market for money and is cash flowing with increasing revenues, building out new facilities and hiring world class team.
A example of real world values in this field is adpt which just did an iPo and has a $6B market cap and a $40 share price. It has less revenue, relies on one product and the team is a shadow of the team in pred.It has about 10% of what pred has! This will be proven out.
Everyone would have loved to sell at $6-90 and buy back yesterday but 1% do that. You are not stupid. It’s the way it is. The company is legit, the people are legit and the relationships are legit. Don’t get caught in the short sighted daily game. Do you’re own homework, I’ve taken a lot of the work out of it for you below. It’s easy to fool one big guy into joining you but you can’t fool the best of the best in the medical world, pfe, tmo, as well as the best Kesha’s minds Wilson sonsini (their partner joined the board) , the top Nasdaq guys, form 10 through the second and also zacks did a full review https://s1.q4cdn.com/460208960/files/News/2019/Zacks_SCR_Research_06112019_PRED_Vandermosten.pdf
This will end and recover and we still have one of the best companies on the street and this will be proven out
Here’s the only thing that matters
Have to add cellsure to this now https://parentsguidecordblood.org/en/news/cellsure-brings-disruptive-innovation-banking-stem-cells
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood (CB), tissue, and placenta storage coupled with increasing number of service providers offering services at competitive prices are the factors driving the market growth.
Here’s my 2 cents for what’s it’s worth
Classic bear raid and attack piece by this Hindenburg group that clearly states he’s short!
“Hindenburg Research (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a short position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein declines. ”
Look at the logic here, the article was totally biased and used info that was completely incorrect to spook people and it worked.
Ex chairman (ex being the key) had sec issues. False and as shown elsewhere they were dropped so therefore no issues.
Company procedures and process are a fraud and don’t work, yet they are at world conferences releasing new data to the best in the world. http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/ Then TMO, one of the largest biotechs in the world does a partnership with them. Who do you think knows more! http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
Let’s look at the team, ex execs from Pfizer, ING, Wyatt, ex president of the American Medical Association, one of the leading senators over the last 100 years and the list goes on. http://predtechgroup.com/about/
The leading attorneys when it comes to biotech Wilson sonsini (they probably have a good idea what’s going on internally) https://www.wsgr.com/WSGR/Display.aspx?SectionName=about the ex senior counsel and ex president of nasdaq is leading their Nasdaq uplist process.https://www.donohoeadvisory.com/about-us/david-a-donohoe-jr/
Let’s also look at the fundamentals
Form 10 passed 30 days ago! If any of this article was remotely true then the would never have passed sec scrutiny and got their form 10! https://www.sec.gov/Archives/edgar/data/1382943/000000000019009260/filename2.txt
Revenues growing q over q! I’m assuming this Q will be the same.
IQVIA (multi billion dollar company) leading one of their fda trials http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
Major partnership with ThermoFisher
It’s hard to look at but this will all wash out and company will uplist and get it’s true value point when the big boys come in. Right now it’s easy to scare retail investors and this was their last chance and they took it. It’s shitty and unfair but it’s the way the market works.
As I always say, do your homework and know what you own
All the recent press and it’s extensive
http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/
http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
http://predtechgroup.com/2019/05/predictive-technology-group-announces-enrollment-milestone-of-200-participants-in-predictive-laboratories-study-for-chronic-joint-and-spine-pain/
http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
http://predtechgroup.com/press/
How this works:
Responding to the article is exactly what they wanted. Quality companies take the higher moral ground. This will all be forgotther about when the company executes.
Here’s the outlook
Higher rev numbers this Q again
Launch on ENDORisk and ArtGuide which will blow up ore revenue numbers
Cellsure just launched (and the company has net even spoken about it yet) more revenues
ThermoFisher deal! More revenues
Nasdaq
This is only the start. Lot more to come.
They have already passed this criteria in the last 3 months so that will also be taken into consideration. I’m looking at very short term given the process started just 3rd in firm 10 approval.
In summary $2 for 5 days hence the hit late yesterday to dip it below 2z
If this goes nasdaq when they are short, all he’ll breaks loose. Nasdaq is close, shorts are smart, that’s why this happened
5505. Initial Listing of Primary Equity Securities
A Company applying to list its Primary Equity Security on the Capital Market must meet all of the requirements set forth in Rule 5505(a) and at least one of the Standards in Rule 5505(b).
(a) Initial Listing Requirements for Primary Equity Securities:
(1) (A) Minimum bid price of $4 per share; or
(B) Minimum closing price of $3 per share, if the Company meets the requirements of the Equity or Net Income Standards under Rules 5505(b)(1) or (b)(3), or of $2 per share, if the Company meets the requirements of the Market Value of Listed Securities Standard under Rule 5505(b)(2), provided that in either case the Company must also demonstrate that it has net tangible assets (i.e., total assets less intangible assets and liabilities) in excess of $2 million, if the issuer has been in continuous operation for at least three years; or net tangible assets in excess of $5 million, if the issuer has been in continuous operation for less than three years; or average revenue of at least $6 million for the last three years. A security must meet the applicable closing price requirement for at least five consecutive business days prior to approval.
For purposes of this paragraph (B), net tangible assets or average revenues must be demonstrated on the Company's most recently filed audited financial statements filed with, and satisfying the requirements of, the Commission or Other Regulatory Authority, and which are dated less than 15 months prior to the date of listing.
(2) At least 1,000,000 Publicly Held Shares;
Silver lining of the last week is that finally most of you guys now know what you own! This is only the start. Much much much bigger things ahead.
May 20tg they reported $11,295,618 for the Q
Total shareholder equity $137,379,102
Pred’s attorneys who facilitated all the m&a in the company . Small
Outfit !!
https://bestlawfirms.usnews.com/profile/wilson-sonsini-goodrich-rosati-pc-llo/rankings/13129
https://chambers-associate.com/wilson-sonsini-goodrich-rosati/true-picture/3676/1
Just a small side bar,
The Auditors who have had their name dragged through the mud BF Borgers rank number 7 in the entire country dealing with otc ! Deloitte are number 6 and KPMG are number 8!
https://blog.auditanalytics.com/who-audits-public-companies-2019-edition/
Then you don’t know who’s around the company!! Funding a non issue
Here the A team of this scam company!!
What are all these people thinking. Did they not read Hindenburg!!
John E. Sorrentino http://predtechgroup.com/2018/03/john-e-sorrentino-full-profile/
Mr. Sorrentino was Vice-President and Chief Operating Officer of Vaccine Research and Development at Pfizer. During his more than 35 years of senior management experience in the life sciences industry, Mr. Sorrentino has held leadership roles in private and public companies, as well as government and non-profit institutions, with a focus on improving public health. Prior to joining Wyeth (acquired by Pfizer) 14 years ago, Mr. Sorrentino held executive positions in several organizations that provided neonatal screening and related clinical services. Mr. Sorrentino’s expertise has had him appear before state legislators, the US Congress and professional societies on a variety of healthcare and policy issues.
John C Nelson http://predtechgroup.com/2018/03/john-c-nelson-full-profile/
Dr. Nelson served as President of the American Medical Association, Salt Lake County Medical Society, and the Utah Medical Association. Also, he chaired the Finance and Planning Committee of the World Medical Association. He served on the Advisory Committee to the Director of the National Institutes of Health (NIH), as well as, on the advisory committee for the Agency for Healthcare Research and Quality
Michael Dey http://predtechgroup.com/2018/03/740/
Dr. Dey had executive positions at Wyeth, later acquired by Pfizer, where he was both the President and the President of Scientific Affairs division for Wyeth’s Women’s Health Care business. As President of Wyeth’s Women’s Health Care business for seven years, Dr. Dey managed its global resources of more than $3 billion
annually.
Ronald Barhorst http://predtechgroup.com/2018/03/ronald-barhorst/
Mr. Barhorst is chair of The California State University Foundation. He is retired as president and chief executive officer of ING Financial Advisers, LLC and ING Investment Advisors, LLC and Systematized Benefits Administrators, Inc.
Senator Orrin G. Hatch http://predtechgroup.com/2019/03/senator-orrin-g-hatch/
Senator Hatch is an attorney and retired politician who served as a U.S. Senator from Utah for 42 years. First elected in 1976, he was the longest-serving Republican U.S. Senator in history. Senator Hatch served as either the chair or ranking minority member of the Senate Judiciary Committee from 1993 to 2005. He previously chaired the Senate Committee on Health, Education, Labor, and Pensions from 1981 to 1987. Senator Hatch also served as Chairman of the Senate Finance Committee. On January 3, 2015, after the 114th United States Congress was sworn in, Hatch became President pro tempore of the Senate. Senator Hatch retired from the U.S. Senate in 2019
Jay M. Moyes http://predtechgroup.com/2019/04/jaymoyes/
Moyes previously served as Chief Financial Officer and Director of the publicly traded biomaterials company Amedica Corporation, now SINTX Technologies, where he managed the company’s IPO and listing on NASDAQ, and as Chief Financial Officer at publicly traded CareDx, a molecular diagnostics company where he introduced a strategy to reach profitability. Prior to that he held senior finance positions including Chief Financial Officer during his 14-year tenure at publicly traded Myriad Genetics. In addition to overseeing all financial aspects at Myriad as the company transitioned from 10 to more than 900 employees, he was instrumental in raising more than $500 million in public and private financings.
Dr. Hugh S. Taylor http://predtechgroup.com/2018/03/dr-hugh-s-taylor/
Dr. Taylor’s many accomplishments include Anita O’Keeffe Young Professor and Chairs Department of Obstetrics Gynecology and Reproductive Sciences at Yale School of Medicine and Chief of Obstetrics, and Gynecology at Yale-New Haven Hospital. He teaches as Professor of Molecular, Cellular and Developmental Biology at Yale University. His clinical interests include endometriosis, infertility, implantation, Asherman’s syndrome, menopause and uterine anomalies
.Also, Dr. Taylor, a board-certified specialist in Obstetrics and Gynecology and in Reproductive Endocrinology, received eight National Institutes of Health research grants. Dr. Taylor published more than 300 articles in leading medical journals, continues as the Editor-In-Chief of Reproductive Sciences, and elected to the membership of the National Academy of Medicine.
DR. DOUGLAS RABIN http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
Dr. Rabin previously served as Medical Director for Women’s Health at Quest Diagnostics, where he successfully completed a seminal paper in cervical cancer screening, initiated a trial in BRCA population testing and helped launch Quest’s non-invasive prenatal and Jewish genetic diagnostics. He also was instrumental in the expansion of the women’s health franchise at Quest through the acquisition of Reprosource, Inc
Christine Seward Senior Vice President of Sales and Marketing of Predictive Laboratories
Ms. Seward brings extensive experience commercializing molecular diagnostics including products in the reproductive space from her 16-year tenure at Myriad Genetics.
Former Taueret Laboratories Chief Operations Officer Lesa Nelson and Director of Quality Assurance Debbie Dyckman http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
Ms. Nelson, who has 27 years in human genetic research including more than 20 years in senior management positions, directs all operational activities and serves as the laboratory Technical Supervisor at Predictive Laboratories. Ms. Dyckman has more than 15 years of experience in clinical trials research and quality assurance and is responsible for licensing, accreditation, document control, lab safety, internal and external inspections, quality assurance reviews and audits,
Feeling stupid is the hard bit. I’m with you in that, sell at 6-90 and buy 4x at 1-60 but the hatchet job was unforeseen. Company will execute and have multiple deals. Thankfully big pharma don’t care about the pps. Higher exchange and higher prices will come.
Adpt iPo was 2 weeks ago and your right the difference is nasdaq and banking. Company’s very similar apart from that so I feel it’s a fair assumption that if ored goes to nasdaq and gas banking support that you could get the same values. Pred revenue growing rapidly from different sources ,cellsure the most recent with the endonrisk revenues to kick it. The thermo deal will be huge with this. If in Nasdaq and using same rev multiple then one could argue that pred doing 100m in revenue could be worth $10B or $30 per share. Even if wrong by half, that’s $15.
The point I’m making is that at $6 it wasn’t over valued, just in the wrong market and set up for this attack
To be honest, the uplist is a distraction but will happen. The company executing in their fundamentals is what’s key and they are doing that. The listing will come sooner or later as the company is if the required standard.
Going to nasdaq isn’t the making of a company. Many nasdaq companies don’t preform. The business execution is key and when you execute in that, then being on nasdaq is helpful. Very helpful.
I have zero concerns
There’s a lot of info available if you do some digging. I’ve been doing this a long time and I’m as bullish at 1-60 as I was at 6-90. Just felt better at 6.90!!
Very well respected industry leaders have left very lucrative positions to join pred and tmo just announced a deal with them. Tmo doesn’t do business with anyone unless they have vetted it thoroughly
Price goes up and down and this is the bears time but this company over the next 6-12 months will be much much higher. Lot of surprises await
It’s 100% legit. Expect official updates next eeek
That’s not the point, you quoted filings and you’re 100% wrong. A slanderous editorial followed by a naked short doesn’t change the fundamentals. Just changed short term sentiment. You asked for dialogue based on facts and filings and then you post BS without any substance. Bring your best, I’ll bounce it straight back
100% legit and more to come. Wouldn’t want to be in the wrong side of this, they are going criminal as fines don’t matter to these scum
100% legit. Really serious guys in more ways than one
Cash flow positive, increasing revenues, no fund raises , new products coming in line. Maybe you should read the financials again
He’s a lowlife , nothing would surprise me. He hid when his people needed him
You’re a donkey?
Wonder what would happen if we got big news after market or pre market Monday !
Have to add cellsure to this now https://parentsguidecordblood.org/en/news/cellsure-brings-disruptive-innovation-banking-stem-cells
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood (CB), tissue, and placenta storage coupled with increasing number of service providers offering services at competitive prices are the factors driving the market growth.
Here’s my 2 cents for what’s it’s worth
Classic bear raid and attack piece by this Hindenburg group that clearly states he’s short!
“Hindenburg Research (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a short position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein declines. ”
Look at the logic here, the article was totally biased and used info that was completely incorrect to spook people and it worked.
Ex chairman (ex being the key) had sec issues. False and as shown elsewhere they were dropped so therefore no issues.
Company procedures and process are a fraud and don’t work, yet they are at world conferences releasing new data to the best in the world. http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/ Then TMO, one of the largest biotechs in the world does a partnership with them. Who do you think knows more! http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
Let’s look at the team, ex execs from Pfizer, ING, Wyatt, ex president of the American Medical Association, one of the leading senators over the last 100 years and the list goes on. http://predtechgroup.com/about/
The leading attorneys when it comes to biotech Wilson sonsini (they probably have a good idea what’s going on internally) https://www.wsgr.com/WSGR/Display.aspx?SectionName=about the ex senior counsel and ex president of nasdaq is leading their Nasdaq uplist process.https://www.donohoeadvisory.com/about-us/david-a-donohoe-jr/
Let’s also look at the fundamentals
Form 10 passed 30 days ago! If any of this article was remotely true then the would never have passed sec scrutiny and got their form 10! https://www.sec.gov/Archives/edgar/data/1382943/000000000019009260/filename2.txt
Revenues growing q over q! I’m assuming this Q will be the same.
IQVIA (multi billion dollar company) leading one of their fda trials http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
Major partnership with ThermoFisher
It’s hard to look at but this will all wash out and company will uplist and get it’s true value point when the big boys come in. Right now it’s easy to scare retail investors and this was their last chance and they took it. It’s shitty and unfair but it’s the way the market works.
As I always say, do your homework and know what you own
All the recent press and it’s extensive
http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/
http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
http://predtechgroup.com/2019/05/predictive-technology-group-announces-enrollment-milestone-of-200-participants-in-predictive-laboratories-study-for-chronic-joint-and-spine-pain/
http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
http://predtechgroup.com/press/
Only one other in the market that’s more expensive and not as good
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood
Another very exciting revenue stream from $pred just about to launch!
https://parentsguidecordblood.org/en/news/cellsure-brings-disruptive-innovation-banking-stem-cells
This scam has been run multiple times. You don’t fight it in a day. You let it play out and over a few weeks the stock probe recovers. This doesn’t effect the company as they are cash flowing and don’t need money. It hurts us shareholders as it’s frightening but as long as the company is fundamentally sound there’s nothing that time won’t fix
There will be zero response from the company . Why give this kind of crap air! That’s what they want. A real company doesn’t deal in the gutter so I don’t see a response .
Company has to just keep executing and the stock will gets its true value off the otc cesspool. Hard for us shareholders to take short term but it’s the smart approach
Here’s my 2 cents for what’s it’s worth
Classic bear raid and attack piece by this Hindenburg group that clearly states he’s short!
“Hindenburg Research (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a short position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein declines. ”
Look at the logic here, the article was totally biased and used info that was completely incorrect to spook people and it worked.
Ex chairman (ex being the key) had sec issues. False and as shown elsewhere they were dropped so therefore no issues.
Company procedures and process are a fraud and don’t work, yet they are at world conferences releasing new data to the best in the world. http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/ Then TMO, one of the largest biotechs in the world does a partnership with them. Who do you think knows more! http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
Let’s look at the team, ex execs from Pfizer, ING, Wyatt, ex president of the American Medical Association, one of the leading senators over the last 100 years and the list goes on. http://predtechgroup.com/about/
The leading attorneys when it comes to biotech Wilson sonsini (they probably have a good idea what’s going on internally) https://www.wsgr.com/WSGR/Display.aspx?SectionName=about the ex senior counsel and ex president of nasdaq is leading their Nasdaq uplist process.https://www.donohoeadvisory.com/about-us/david-a-donohoe-jr/
Let’s also look at the fundamentals
Form 10 passed 30 days ago! If any of this article was remotely true then the would never have passed sec scrutiny and got their form 10! https://www.sec.gov/Archives/edgar/data/1382943/000000000019009260/filename2.txt
Revenues growing q over q! I’m assuming this Q will be the same.
IQVIA (multi billion dollar company) leading one of their fda trials http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
Major partnership with ThermoFisher
It’s hard to look at but this will all wash out and company will uplist and get it’s true value point when the big boys come in. Right now it’s easy to scare retail investors and this was their last chance and they took it. It’s shitty and unfair but it’s the way the market works.
As I always say, do your homework and know what you own
All the recent press and it’s extensive
http://predtechgroup.com/2019/06/thermo-fisher-scientific-and-predictive-laboratories-announce-global-infertility-research-collaboration/
http://predtechgroup.com/2019/05/predictive-biotech-signs-letter-of-intent-with-iqvia-to-begin-clincial-trial-for-osteoarthritis-of-the-knee/
http://predtechgroup.com/2019/06/predictive-technology-group-announces-the-presentation-of-new-data-demonstrating-the-genetic-basis-of-endometriosis-at-eshre/
http://predtechgroup.com/2019/06/predictive-technology-group-names-industry-veteran-dr-douglas-rabin-vice-president-of-medical-affairs-womens-health-of-predictive-laboratories/
http://predtechgroup.com/2019/05/predictive-technology-group-announces-enrollment-milestone-of-200-participants-in-predictive-laboratories-study-for-chronic-joint-and-spine-pain/
http://predtechgroup.com/2019/04/predictive-technology-group-names-christine-seward-senior-vice-president-of-sales-and-marketing-of-predictive-laboratories/
http://predtechgroup.com/press/